Leverage the latest in AI technology for informed, fast, and effective clinical trials
Enable objective, quantitative comparisons between patients, cohorts, and treatments
Stop waiting for test results
Ensure you screen for the right patients at the morphological level
See how your samples compare to a well-curated and highly annotated cohort. Samples viewed in disease space allow for a nuanced interpretation of certainty.
Get more from your existing data and workflows
See the forest for the trees - our biomarkers scrutinise millions of cells and reams of fibrosis along with molecular and other data to get the complete picture.
A better way to analyse everything in context
Our platform enables multi-modal analysis and interpretation for a composite view of patient data including, molecular, demographic and histopathological; all against the backdrop of the wider disease space